Two healthy diets modulate gut microbial community improving insulin sensitivity in a human obese population

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 1, 2016, Pages 233-242

  Haro, Carmen ^a,b   Montes Borrego, Miguel ^c   Rangel Zúñiga, Oriol A ^a,b   Alcalã Diaz, Juan F ^a,b   Gamez Delgado, Francisco ^a,b   Pérez Martinez, Pablo ^a,b   Delgado Lista, Javier ^a,b   Quintana Navarro, Gracia M ^a,b   Tinahones, Francisco J ^a,b,d   Landa, Blanca B ^c   Lapez Miranda, José ^b   Camargo, Antonio ^a,b   Pérez Jiménez, Francisco ^a,b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE AGRICULTURA SOSTENIBLE   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIUM; CARBOHYDRATE DIET; CLINICAL ARTICLE; CONTROLLED STUDY; FAECALIBACTERIUM PRAUSNITZII; HUMAN; INSULIN SENSITIVITY; INTESTINE FLORA; ISCHEMIC HEART DISEASE; LOW FAT DIET; LOW FAT HIGH COMPLEX CARBOHYDRATE DIET; MALE; MEDITERRANEAN DIET; METABOLOME; MICROBIAL COMMUNITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSCILLOSPIRA; OUTCOME ASSESSMENT; PARABACTEROIDES DISTASONIS; PREVOTELLA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ROSEBURIA; SPECIES COMPOSITION; THERAPY EFFECT; CHEMISTRY; DIET; DIET THERAPY; FECES; FEMALE; GASTROINTESTINAL TRACT; GENETICS; INSULIN RESISTANCE; METABOLISM; MICROBIOLOGY; MICROFLORA; MIDDLE AGED;

BACTERIAL DNA; CARBOHYDRATE DIET; OLIVE OIL;

DIET; DIET, FAT-RESTRICTED; DIET, MEDITERRANEAN; DIETARY CARBOHYDRATES; DNA, BACTERIAL; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INSULIN RESISTANCE; MALE; METABOLOME; MICROBIOTA; MIDDLE AGED; OBESITY; OLIVE OIL; PROSPECTIVE STUDIES;

EID: 84954562293     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3351     Document Type: Article

References (40)

1. Bays HE, González-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008;6:343-368.
2. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-1031.
3. Cani PD, Delzenne NM, Amar J, Burcelin R. Role of gut microflora in the development of obesity and insulin resistance following highfat diet feeding. Pathol Biol (Paris). 2008;56:305-309.
4. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol. 2010;26:5-11.
5. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7:887-894.
6. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136:65-80.
7. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489:242-249.
8. Caesar R, Fåk F, Bäckhed F. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med. 2010;268:320-328.
9. Johnson AM, Olefsky JM. The origins and drivers of insulin resistance. Cell. 2013;152:673-684.
10. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. Host-gut microbiota metabolic interactions. Science. 2012;336:1262-1267.
11. Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Mol Aspects Med. 2013;34:39-58.
12. DeFilippo C, Cavalieri D, Di PaolaM,et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad SciUSA. 2010;107:14691-14696.
13. Moschen AR, Wieser V, Tilg H. Dietary factors: Major regulators of the gut's microbiota. Gut Liver. 2012;6:411-416.
14. Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology. 2012; 142:1100-1101.e2.
15. Ghanim H, Abuaysheh S, Sia CL, et al. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: Implications for insulin resistance. Diabetes Care. 2009;32:2281-2287.
16. Ghanim H, Sia CL, Korzeniewski K, et al. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab. 2011;96:1409-1414.
17. Ghanim H, Sia CL, Upadhyay M, et al. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression.AmJ Clin Nutr. 2010;91:940-949.
18. Vanhoutte T, De Preter V, De Brandt E, Verbeke K, Swings J, Huys G. Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl Environ Microbiol. 2006;72:5990-5997.
19. Zoetendal EG, Akkermans AD, De VosWM.Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol. 1998;64:3854-3859.
20. Queipo-Ortuño MI, Boto-Ordóñez M, Murri M, et al. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr. 2012;95:1323-1334.
21. Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334:105-108.
22. Haro C, Garcia-Carpintero S, Alcala-Diaz JF, et al. The gut microbial community in metabolic syndrome patients is modified by diet [published online ahead of print August 20, 2015]. J Nutr Biochem. doi:10.1016/j.jnutbio.2015.08.011.
23. Garcia-Rios A, Gomez-Delgado FJ, Garaulet M, et al. Beneficial effect of CLOCK gene polymorphism rs1801260 in combination with low-fat diet on insulin metabolism in the patients with metabolic syndrome. Chronobiol Int. 2014;31:401-408.
24. Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA. Polysaccharide utilization by gut bacteria: Potential for new insights from genomic analysis. Nat Rev Microbiol. 2008;6:121-131.
25. Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498:99-103.
26. Qin J, Li Y, Cai Z, et al.Ametagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55-60.
27. Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and low-grade inflammation markers. Diabetes. 2010;59: 3049-3057.
28. Hatziioanou D, Mayer MJ, Duncan SH, Flint HJ, Narbad A. A representative of the dominant human colonic Firmicutes, Roseburia faecis M72/1, forms a novel bacteriocin-like substance. Anaerobe. 2013;23:5-8.
29. Aminov RI, Walker AW, Duncan SH, Harmsen HJ, Welling GW, Flint HJ. Molecular diversity, cultivation, and improved detection by fluorescent in situ hybridization of a dominant group of human gut bacteria related to Roseburia spp. or Eubacterium rectale. Appl Environ Microbiol. 2006;72:6371-6376.
30. KastoriniCM,Panagiotakos DB. Dietary patterns and prevention of type 2 diabetes: From research to clinical practice; a systematic review. Curr Diabetes Rev. 2009;5:221-227.
31. Schröder H. Protective mechanisms of the Mediterranean diet in obesity and type 2 diabetes. J Nutr Biochem. 2007;18:149-160.
32. Mackie RI, Aminov RI, Hu W, et al. Ecology of uncultivated Oscillospira species in the rumen of cattle, sheep, and reindeer as assessed by microscopy and molecular approaches. Appl Environ Microbiol. 2003;69:6808-6815.
33. De Lorgeril M, Salen P, Martin JL, Mamelle N, Monjaud I, Touboul P, Delaye J. Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments. J Am Coll Cardiol. 1996;28:1103-1108.
34. Mena MP, Sacanella E, Vazquez-Agell M, et al. Inhibition of circulating immune cell activation: A molecular antiinflammatory effect of the Mediterranean diet. Am J Clin Nutr. 2009;89:248-256.
35. Fernandes J, Su W, Rahat-Rozenbloom S, Wolever TM, Comelli EM. Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diabetes. 2014;4:e121.
36. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: Fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235-243.
37. Ichimura A, Hirasawa A, Hara T, Tsujimoto G. Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis. Prostaglandins Other Lipid Mediat. 2009;89:82-88.
38. Duncan SH, Aminov RI, Scott KP, Louis P, Stanton TB, Flint HJ. Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces. Int J Syst Evol Microbiol. 2006;56:2437-2441.
39. Fuller M. Determination of protein and amino acid digestibility in foods including implications of gut microbial amino acid synthesis. Br J Nutr. 2012;108(suppl 2):S238-S246.
40. Stein HH, Sève B, Fuller MF, Moughan PJ, de Lange CF, Committee on Terminology to Report AA Bioavailability and Digestibility. Invited review: Amino acid bioavailability and digestibility in pig feed ingredients: Terminology and application. J Anim Sci. 2007;85:172-180.